Comparison of Triflusal With Aspirin in the Secondary Prevention of Atherothrombotic Events

Trial Profile

Comparison of Triflusal With Aspirin in the Secondary Prevention of Atherothrombotic Events

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Triflusal (Primary) ; Aspirin
  • Indications Coronary artery disease; Myocardial infarction; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ASTERIAS
  • Most Recent Events

    • 13 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 30 May 2017 Planned End Date changed from 1 Feb 2017 to 31 Aug 2017.
    • 30 May 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top